University of Wisconsin–Madison

Category: Publications

Macular pigment optical density in a midwestern sample.

PubMed ID: 11297490 Author(s): Ciulla TA, Curran-Celantano J, Cooper DA, Hammond BR Jr, Danis RP, Pratt LM, Riccardi KA, Filloon TG. Macular pigment optical density in a midwestern sample. Ophthalmology. 2001 Apr;108(4):730-7. PMID 11297490 Journal: Ophthalmology, Volume 108, Issue 4, Apr 2001 OBJECTIVE To assess the distribution of the macular pigments (MPs) lutein (L) and …

Intravitreal triamcinolone acetonide inhibits choroidal neovascularization in a laser-treated rat model.

PubMed ID: 11231773 Author(s): Ciulla TA, Criswell MH, Danis RP, Hill TE. Intravitreal triamcinolone acetonide inhibits choroidal neovascularization in a laser-treated rat model. Arch Ophthalmol. 2001 Mar;119(3):399-404. PMID 11231773 Journal: Archives Of Ophthalmology (Chicago, Ill. : 1960), Volume 119, Issue 3, Mar 2001 OBJECTIVE To determine if intravitreal triamcinolone acetonide (TAAC) inhibits experimental choroidal neovascular …

Anti-angiogenic therapy of proliferative diabetic retinopathy.

PubMed ID: 11336594 Author(s): Danis RP, Ciulla TA, Criswell M, Pratt L. Anti-angiogenic therapy of proliferative diabetic retinopathy. Expert Opin Pharmacother. 2001 Mar;2(3):395-407. Review. Erratum in: Expert Opin Pharmacother 2001 Apr;2(4):727. PMID 11336594 Journal: Expert Opinion On Pharmacotherapy, Volume 2, Issue 3, Mar 2001 Proliferative diabetic retinopathy (PDR) remains one of the major causes of …

Potential therapeutic application of antisense oligonucleotides in the treatment of ocular diseases.

PubMed ID: 11336586 Author(s): Danis RP, Henry SP, Ciulla TA. Potential therapeutic application of antisense oligonucleotides in the treatment of ocular diseases. Expert Opin Pharmacother. 2001 Feb;2(2):277-91. Review. PMID 11336586 Journal: Expert Opinion On Pharmacotherapy, Volume 2, Issue 2, Feb 2001 Antisense oligonucleotides are a class of compounds being developed as therapeutic agents for many …